Exosomes derived from HER2+ breast cancer cells carry lncRNA-SNHG14, which can induce apoptosis and trastuzumab resistance by targeting the B-cell lymphoma-2 gene (Bcl-2)/BAX pathway [62]. This evidence concerns the gene ERBB2 and breast cancer.